VYEPTI

eptinezumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for VYEPTI, covering 2020-02-21 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine [Phase 3]